English | Español
Patient Daily | Jun 12, 2026

Novartis reports positive Phase 1/2 results for muscular dystrophy drug after Avidity buy
Patient Daily | Jun 12, 2026

Amgen enlists Duke for Tavneos FDA review amid safety concerns and withdrawal request
Patient Daily | Jun 12, 2026

Montana State University scientist discovers backup cysteine creation process in cells
Patient Daily | Jun 12, 2026

Study finds people unconsciously filter out negative words before awareness
Patient Daily | Jun 12, 2026

UC Riverside study finds immune pathway linked to long-term concussion effects
Patient Daily | Jun 12, 2026

UC Davis researchers receive NIH grant to test new vascularized bladder grafts for children
Patient Daily | Jun 12, 2026

Researchers develop injectable wireless device to control nerve activity without surgery
Patient Daily | Jun 12, 2026

FDA approves pembrolizumab and belzutifan combination for ccRCC patients at recurrence risk

Trending
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
A. R. Baird | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science